Cell Impact reports third quarter results: Product and production adjustments result in temporarily lower sales
Cell Impact AB (Nasdaq First North GM: CI) reports the following financial summary for the third quarter.· Total revenues amounted to SEK 14.7 million (27.5), down -46% compared with the corresponding Quarter of 2021. · Operating loss was SEK -28.6 million (-14.4). · The Group's loss after financial items was SEK -28.9 million (-14.7). · Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.38 (-0.25). · Equity was SEK 353.3 million (149.3) or SEK 4.66 per share (2.54) on the balance sheet date. · Debt/equity ratio was 81% (73) on the